0001562180-18-004455.txt : 20181107
0001562180-18-004455.hdr.sgml : 20181107
20181107181834
ACCESSION NUMBER: 0001562180-18-004455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181105
FILED AS OF DATE: 20181107
DATE AS OF CHANGE: 20181107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUDNICK SETH
CENTRAL INDEX KEY: 0001184420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 181167709
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
STREET 2: C/O ARALEZ PHARMACEUTICALS
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: P. O. BOX # 110341
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2018-11-05
false
0001560241
G1 Therapeutics, Inc.
GTHX
0001184420
RUDNICK SETH
C/O G1 THERAPEUTICS, INC.
79 T.W. ALEXANDER DRIVE
RESEARCH TRIANGLE PARK
NC
27709
true
false
false
false
Common Stock
2018-11-05
4
M
false
10000.00
0.39
A
10000.00
D
Common Stock
2018-11-05
4
S
false
10000.00
41.5347
D
0.00
D
Common Stock
58282.00
I
See Footnote
Stock Options (Right to Buy)
0.39
2018-11-05
4
M
false
10000.00
0.00
D
2024-01-21
Common Stock
10000.00
607.00
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
The price represents the weighted average price with a low of $41.38 and a high of $41.99. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
All shares underlying this option have vested.
/s/ James Stillman Hanson, attorney-in-fact
2018-11-07